TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
114.00
+4.80 (4.40%)
At close: Apr 10, 2026, 4:00 PM EDT
114.12
+0.12 (0.11%)
After-hours: Apr 10, 2026, 7:32 PM EDT
TransMedics Group Market Cap
TransMedics Group has a market cap or net worth of $3.91 billion as of April 10, 2026. Its market cap has increased by 65.20% in one year.
Market Cap
3.91B
Enterprise Value
3.94B
1-Year Change
65.20%
Ranking
Category
Stock Price
$114.00
Market Cap Chart
Since May 2, 2019, TransMedics Group's market cap has increased from $452.48M to $3.91B, an increase of 764.23%. That is a compound annual growth rate of 36.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 3.91B | -5.94% |
| Dec 31, 2025 | 4.16B | 98.67% |
| Dec 31, 2024 | 2.09B | -18.79% |
| Dec 29, 2023 | 2.58B | 30.78% |
| Dec 30, 2022 | 1.97B | 270.34% |
| Dec 31, 2021 | 532.04M | -1.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 2, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Rad Laboratories | 7.54B |
| Bio-Rad Laboratories | 7.53B |
| Glaukos | 6.76B |
| Bruker | 5.72B |
| iRhythm Holdings | 3.72B |
| LivaNova | 3.43B |
| Integer Holdings | 2.90B |
| Haemonetics | 2.66B |